These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7275221)
21. Natural products and antifungal drug discovery. Jacob MR; Walker LA Methods Mol Med; 2005; 118():83-109. PubMed ID: 15888937 [TBL] [Abstract][Full Text] [Related]
22. [A new problem: multiresistant fungi]. Wehr A Dtsch Med Wochenschr; 1997 Mar; 122(11):A9. PubMed ID: 9102278 [No Abstract] [Full Text] [Related]
23. [Newer antimycotics. VII. N-aryl-dithiocarbamic-esters and carbylaminochlorides (author's transl)]. Zsolnai T Zentralbl Bakteriol A; 1980 Aug; 247(3):410-7. PubMed ID: 7424251 [TBL] [Abstract][Full Text] [Related]
24. Chiral gamma-aryl-1H-1,2,4-triazole derivatives as highly potential antifungal agents: Design, synthesis, structure, and in vitro fungicidal activities. Cao X; Li F; Hu M; Lu W; Yu GA; Liu SH J Agric Food Chem; 2008 Dec; 56(23):11367-75. PubMed ID: 18998696 [TBL] [Abstract][Full Text] [Related]
26. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Boeck P; Leal PC; Yunes RA; Filho VC; López S; Sortino M; Escalante A; Furlán RL; Zacchino S Arch Pharm (Weinheim); 2005 Mar; 338(2-3):87-95. PubMed ID: 15799012 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and in-vitro antifungal activity of 6-substituted-phenyl-2- {[(4'-substituted phenyl-5'-thioxo)-1,2,4-triazol-3-yl]-methyl}-2,3,4,5-tetrahydropyridazin-3-one derivatives. Siddiqui AA; Ahamad SR; Mira MS; Hussain SA; Raish M; Kaur R Acta Pol Pharm; 2008; 65(2):223-8. PubMed ID: 18666429 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes. Ng CK; Singhal V; Widmer F; Wright LC; Sorrell TC; Jolliffe KA Bioorg Med Chem; 2007 May; 15(10):3422-9. PubMed ID: 17383187 [TBL] [Abstract][Full Text] [Related]
33. [Microbial sensitivity tests with antifungal agents and their determination in body fluids]. Vazzana A Quad Sclavo Diagn; 1981 Mar; 17(1):115-22. PubMed ID: 7313067 [No Abstract] [Full Text] [Related]
34. An overview of the antifungal properties of allicin and its breakdown products--the possibility of a safe and effective antifungal prophylactic. Davis SR Mycoses; 2005 Mar; 48(2):95-100. PubMed ID: 15743425 [TBL] [Abstract][Full Text] [Related]
35. [Antimycotic and antibacterial efficacy of 1,3-benzoxathioles and hydroxybenzaldehydes]. Fiedler H; Kaben U Pharmazie; 1966 Mar; 21(3):178-80. PubMed ID: 5987583 [No Abstract] [Full Text] [Related]
36. Studies on the antifungal effect of flucytosine (ancobon, ancotil). Abou-Gabal M; Graham D Mykosen; 1978 Oct; 21(10):349-54. PubMed ID: 732861 [No Abstract] [Full Text] [Related]
37. A case for two-component signaling systems as antifungal drug targets. Shor E; Chauhan N PLoS Pathog; 2015 Feb; 11(2):e1004632. PubMed ID: 25723524 [No Abstract] [Full Text] [Related]
38. [Preparation and antifungal activity of bz.methyl-substituted bis-(2-carboxyamidophenyl)disulfides and 1,2-benzoisothiazoline-3-ones]. Ponci R; Vitali T; Amoretti L; Mossini F Farmaco Sci; 1967 Nov; 22(11):935-46. PubMed ID: 6077145 [No Abstract] [Full Text] [Related]
39. [Statistical analysis of biological test data: the possibility of rationalization of screening]. Hagemann R; Franke R Pharmazie; 1976; 31(2):130-1. PubMed ID: 959255 [No Abstract] [Full Text] [Related]